sb 203580 has been researched along with astressin-2b in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (astressin-2b) | Trials (astressin-2b) | Recent Studies (post-2010) (astressin-2b) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 41 | 0 | 30 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Caimmi, PP; Grossini, E; Mary, DA; Molinari, C; Ribichini, F; Uberti, F; Vacca, G | 1 |
1 other study(ies) available for sb 203580 and astressin-2b
Article | Year |
---|---|
Urocortin II induces nitric oxide production through cAMP and Ca2+ related pathways in endothelial cells.
Topics: Androstadienes; Animals; Aorta; Blotting, Western; Butadienes; Calcimycin; Calcium; Cells, Cultured; Colforsin; Cyclic AMP; Dideoxyadenosine; Endothelial Cells; Imidazoles; Ionophores; Mitogen-Activated Protein Kinase 3; Nitric Oxide; Nitriles; Oncogene Protein v-akt; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Peptides, Cyclic; Pyridines; Signal Transduction; Swine; Urocortins; Wortmannin | 2009 |